Penile erections were regularly induced by intermittent subcutaneous injections of apomorphine in five patients with Parkinson's disease (PD) complicated by motor fluctuations. Four of the patients reported erectile dysfunction before beginning apomorphine and mio of these report a significant improvement in their sexual function resulting from apomorphine use. Animal studies suggest central D2-type dopamine receptor stimulation and oxytocin release from the paraven tricular nucleus of the hypothalamus mediate the effect, Erections reported with other dopamine agonists and levodopa are probably mediated by the same mechanism. Apomorphine-induced erections in PD are probably more common than previously thought. The benefit of apomorphine on ...
Apomorphine is a dopamine receptor agonist that was recently licensed for the treatment of erectile ...
The understanding of the scientific basis of the erectile function expanded rapidly the range of the...
The effect of PD-168077 (N-methyl-4-(2-cyanophenyl)piperazynil-3-methylbenzamide maleate), a selecti...
It is well recognized that sexual stimulation leading to penile erection is controlled by different ...
The effect of a pro-erectile dose of apomorphine, a mixed dopamine receptor agonist, and of PD-16807...
To report the case of a patient, who in the context of an anti-Parkinsonian therapy, developed addic...
Apomorphine, a nonselective dopamine receptor agonist, facilitates penile erection and is effective ...
Among neurotransmitters involved in the control of erectile function and sexual behavior, dopamine i...
Drugs that stimulate dopamine (DA) systems can stimulate sexual arousal in male rats and humans, and...
Nonmotor symptoms, among them sexual dysfunction, are common and underrecognized in patients with Pa...
Apomorphine is a non-selective dopaminergic receptor agonist. Because of its pro-erectile effects, a...
Apomorphine is a non-selective dopaminergic receptor agonist. Because of its pro-erectile effects, a...
Apomorphine, given subcutaneously (s.c.), induces erection and bladder overactivity in rats through ...
The understanding of the scientific basis of the erectile function expanded rapidly the range of the...
Pramipexole, a dopamine D3/D2 receptor agonist, induces penile erection when administered subcutaneo...
Apomorphine is a dopamine receptor agonist that was recently licensed for the treatment of erectile ...
The understanding of the scientific basis of the erectile function expanded rapidly the range of the...
The effect of PD-168077 (N-methyl-4-(2-cyanophenyl)piperazynil-3-methylbenzamide maleate), a selecti...
It is well recognized that sexual stimulation leading to penile erection is controlled by different ...
The effect of a pro-erectile dose of apomorphine, a mixed dopamine receptor agonist, and of PD-16807...
To report the case of a patient, who in the context of an anti-Parkinsonian therapy, developed addic...
Apomorphine, a nonselective dopamine receptor agonist, facilitates penile erection and is effective ...
Among neurotransmitters involved in the control of erectile function and sexual behavior, dopamine i...
Drugs that stimulate dopamine (DA) systems can stimulate sexual arousal in male rats and humans, and...
Nonmotor symptoms, among them sexual dysfunction, are common and underrecognized in patients with Pa...
Apomorphine is a non-selective dopaminergic receptor agonist. Because of its pro-erectile effects, a...
Apomorphine is a non-selective dopaminergic receptor agonist. Because of its pro-erectile effects, a...
Apomorphine, given subcutaneously (s.c.), induces erection and bladder overactivity in rats through ...
The understanding of the scientific basis of the erectile function expanded rapidly the range of the...
Pramipexole, a dopamine D3/D2 receptor agonist, induces penile erection when administered subcutaneo...
Apomorphine is a dopamine receptor agonist that was recently licensed for the treatment of erectile ...
The understanding of the scientific basis of the erectile function expanded rapidly the range of the...
The effect of PD-168077 (N-methyl-4-(2-cyanophenyl)piperazynil-3-methylbenzamide maleate), a selecti...